Related Experiment Video

Updated: Jul 25, 2026

Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells
16:24

Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells

Published on: February 21, 2014

RERG is a novel ras-related, estrogen-regulated and growth-inhibitory gene in breast cancer

B S Finlin1, C L Gau, G A Murphy

  • 1Department of Molecular and Cellular Biochemistry, University of Kentucky College of Medicine, Lexington, Kentucky 40536, USA.

The Journal of Biological Chemistry
|September 5, 2001
PubMed

Insights

A novel gene, ras-related and estrogen-regulated growth inhibitor (RERG), is frequently lost in aggressive breast tumors. Its restoration inhibits breast cancer growth, suggesting RERG’s tumor-suppressive role.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Ras superfamily genes play crucial roles in cell signaling and cancer.
  • Decreased expression of certain genes in breast tumors often correlates with poor prognosis.

Purpose of the Study:

  • To identify and characterize a novel ras superfamily gene, RERG, and investigate its role in breast tumorigenesis.
  • To explore the relationship between RERG expression and breast tumor characteristics and patient outcomes.

Main Methods:

  • Microarray analysis to identify RERG expression in human breast tumors.
  • Hormone stimulation (beta-estradiol) and inhibition (tamoxifen) assays in MCF-7 cells.
  • Biochemical assays to determine RERG protein's GDP/GTP binding and hydrolysis activity.
  • In vitro cell growth assays and in vivo tumor formation studies in nude mice.

Main Results:

  • RERG expression was decreased or lost in a significant percentage of primary human breast tumors with poor prognosis.
  • High RERG expression correlated with estrogen receptor-positive breast tumors, slow proliferation, and favorable prognosis.
  • RERG protein exhibited GDP/GTP binding and hydrolysis activity but lacked prenylation, localizing to the cytoplasm.
  • RERG expression inhibited breast cancer cell growth in vitro and tumor formation in vivo.

Conclusions:

  • RERG is a unique ras superfamily protein with tumor-suppressive functions in breast cancer.
  • Loss of RERG expression may contribute to breast tumorigenesis and is associated with aggressive tumor subtypes.
  • RERG represents a potential therapeutic target for breast cancer treatment.

More Related Videos

An In Vitro Dormancy Model of Estrogen-sensitive Breast Cancer in the Bone Marrow: A Tool for Molecular Mechanism Studies and Hypothesis Generation08:48

An In Vitro Dormancy Model of Estrogen-sensitive Breast Cancer in the Bone Marrow: A Tool for Molecular Mechanism Studies and Hypothesis Generation

Published on: June 30, 2015

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans08:12

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans

Published on: October 5, 2020

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...